New psoriasis drug shows promise in early trial
Symptom relief
Completed
This study tested a new drug called AX-158 in 31 adults with mild to moderate plaque psoriasis. Participants took either the drug or a placebo for 28 days, then were monitored for 30 more days to check safety. The main goal was to see if the drug is safe and tolerable, with some …
Phase: PHASE1, PHASE2 • Sponsor: Artax Biopharma Inc • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC